Literature DB >> 156110

Studies on the mode of action of 5-fluorocytosine in Aspergillus species.

G E Wagner, S Shadomy.   

Abstract

The mode of action of 5-fluorocytosine (5-FC) was studied in three isolates of pathogenic Aspergillus with varying degrees of susceptibility to the drug. Distribution studies showed that susceptibility or resistance to 5-FC was not dependent on uptake of the drug. While only a small percentage of the total 5-FC taken up was found in the RNA fraction of the cells, most remained in the acid-soluble intracellular pool. 5-FC, 5-fluorouracil (5-FU) and 5-fluorodeoxyuridine monophosphate (5-Fd-UMP) were among metabolites identified in the pool. In addition, fluoroorotic acid appeared to be a major constituent of the metabolites derived from 5-FC. The aspergilli also were capable of utilizing cytosine as a nitrogen source and this is suggested as a possible mechanism of resistance. A dual mode of action for 5-FC in the aspergilli is proposed. This consists of, first, incorporation of 5-FU into RNA and, second, inhibition of DNA synthesis by production of 5-FdUMP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156110     DOI: 10.1159/000237824

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  Study of the metabolism of flucytosine in Aspergillus species by 19F nuclear magnetic resonance spectroscopy.

Authors:  N Chouini-Lalanne; M C Malet-Martino; R Martino; G Michel
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  Noninvasive and quantitative 19F nuclear magnetic resonance study of flucytosine metabolism in Candida strains.

Authors:  J P Vialaneix; N Chouini; M C Malet-Martino; R Martino; G Michel; J P Lepargneur
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (WNS) in bats.

Authors:  Sudha Chaturvedi; Sunanda S Rajkumar; Xiaojiang Li; Gregory J Hurteau; Michael Shtutman; Vishnu Chaturvedi
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.